VANCOUVER, BC / ACCESSWIRE / March 28, 2017 / - Laguna Blends Inc. (CSE: LAG) (OTC Pink: LAGBF) (FSE: LB6A) (the "Company" or "Laguna") is pleased to announce that it has appointed Marcos Agramont as its Chief Operating Officer (COO) effective immediately.
Mr. Agramont has been a leading innovator in the Cannabis Industry for the last five years developing products for domestic and international channels. He has pioneered delivery systems, regulations and processes for major brands in order to meet safety standards and compliance. He was instrumental in implementing innovative delivery apparatuses with concise servings, at a time when no accurate measuring of dosage for general usage existed.
Mr. Grimm, Laguna's CEO and President stated: "We are very excited to add Mr. Agramont's pedigree and experience to our executive management team. As part of our growth stage ahead, we will continue to reinforce our management team with industry leaders who add substantial credibility to the Company. Mr. Agramont will be an instrumental part in expanding Laguna Blends' international presence in multiple key pharmaceutical and supplements categories."
Mr. Agramont has helped introduce CBD to the pharmaceutical global markets including Japan, Latin America, the European Union and Australia. He intends to make a continued contribution to the industry by joining Laguna Blends and will help bring the Company and its family of brands to the forefront of Cannabis Bioscience and CBD Pharmaceuticals.
The Company also announces that it has granted stock options to directors and officers to purchase up to 1,400,000 common shares at $0.16 per share for a two year period.
About Laguna Blends Inc.
Laguna Blends is located in Vancouver, British Columbia and Escondido, California and is focused on drug development of topical products containing CBD and THCV as the active pharmaceutical ingredient. Laguna is also engaged in the development, marketing and sales of hemp derived phytocannabinoid consumer products.
Lagunas' growth strategy includes acquiring and incubating companies that formulate and/or manufacture hemp derived products and cannabis based pharmaceuticals. Laguna is currently seeking joint ventures and acquisitions to expand its portfolio.
Forward-Looking Information: This news release contains "forward-looking information" within the meaning of applicable securities laws relating to statements regarding the Company's business, products and future the Company's business, its product offerings and plans for sales and marketing. Although the Company believes that the expectations reflected in the forward looking information are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned to not place undue reliance on forward-looking information. Such forward looking statements are subject to risks and uncertainties that may cause actual results, performance and developments to differ materially from those contemplated by these statements depending on, among other things, the risks that the Company's products and plan will vary from those stated in this news release and the Company may not be able to carry out its business plans as expected. Except as required by law, the Company expressly disclaims any obligation, and does not intend, to update any forward looking statements or forward-looking information in this news release. Although the Company believes that the expectations reflected in the forward looking information are reasonable, there can be no assurance that such expectations will prove to be correct and makes no reference to profitability based on sales reported. The statements in this news release are made as of the date of this release.
The CSE has not reviewed, approved or disapproved the content of this press release.